Structural Insights into the Pharmacophore of Vinca Domain Inhibitors of Microtubules | |
Wang, YX; Benz, FW; Wu, YP; Wang, QS; Chen, YF; Chen, XZ; Li, HY; Zhang, YH; Zhang, RD; Yang, JL | |
刊名 | MOLECULAR PHARMACOLOGY |
2016 | |
卷号 | 89期号:2页码:233—242 |
关键词 | TUBULIN CHEMOTHERAPY COLCHICINE AGENTS LIGANDS |
ISSN号 | 0026-895X |
通讯作者 | Zhang, RD ; Yang, JL (reprint author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, 3-17 Renmin South Rd, Chengdu 610041, Peoples R China. ; Zhang, RD ; Yang, JL (reprint author), Sichuan Univ, West China Hosp, Ctr Canc, 3-17 Renmin South Rd, Chengdu 610041, Peoples R China. ; Zhang, RD ; Yang, JL (reprint author), Collaborat Innovat Ctr Biotherapy, 3-17 Renmin South Rd, Chengdu 610041, Peoples R China. |
英文摘要 | Antibody-drug conjugates (ADCs) have achieved great success in cancer therapy in recent years. Some peptidyl microtubule inhibitors consisting of natural and unnatural amino acids, such as monomethyl auristatin E (MMAE) and F (MMAF), are extremely cytotoxic and have been used as a payload in ADCs. However, their precise molecular interaction with tubulin and microtubules remains unclear. We determined the crystal structures of tubulin in complex with three ultra-potent peptidyl microtubule inhibitors [MMAE, taltobulin (HTI-286), and tubulysin M] at 2.5 angstrom. Our data showed that the three peptides bound to the vinca domain and shared a common and key pharmacophore containing two consecutive hydrophobic groups (Val, Ile-like side chain). These groups protruded in opposite directions into hydrophobic pockets on the tubulin beta and alpha subunits. Nitrogen and oxygen atoms from the same backbone formed hydrogen bonds with Asn329 from the a subunit and Asp179 from the beta subunit in a direction normal to the surface formed by the aforementioned hydrophobic groups. In addition, our crystal structure data indicated that tubulysin M bound to the beta subunit alone, providing a structural explanation for its higher affinity. We also compared the conformations of two representative structurally different vinca domain compounds, ustiloxin D and vinblastine, with those of the aforementioned peptidyl ligands, and found that they shared a similar pharmacophore. Our findings lay a foundation for the rational design of novel vinca domain ligands and may facilitate the development of microtubule inhibitors with high specificity, affinity, and efficiency as payloads for ADCs in cancer therapy. |
收录类别 | SCI |
语种 | 英语 |
WOS记录号 | WOS:000369305700003 |
内容类型 | 期刊论文 |
源URL | [http://ir.sinap.ac.cn/handle/331007/25843] |
专题 | 上海应用物理研究所_中科院上海应用物理研究所2011-2017年 |
推荐引用方式 GB/T 7714 | Wang, YX,Benz, FW,Wu, YP,et al. Structural Insights into the Pharmacophore of Vinca Domain Inhibitors of Microtubules[J]. MOLECULAR PHARMACOLOGY,2016,89(2):233—242. |
APA | Wang, YX.,Benz, FW.,Wu, YP.,Wang, QS.,Chen, YF.,...&Yang, JL.(2016).Structural Insights into the Pharmacophore of Vinca Domain Inhibitors of Microtubules.MOLECULAR PHARMACOLOGY,89(2),233—242. |
MLA | Wang, YX,et al."Structural Insights into the Pharmacophore of Vinca Domain Inhibitors of Microtubules".MOLECULAR PHARMACOLOGY 89.2(2016):233—242. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论